Orally administered epeleuton inhibits SARS-CoV-2 viral load, replication and pathology in the Syrian Hamster model
J. Climax, M. Hamza, A. Lafferty…·D. Coughlan
This study shows that epeleuton reduces SARS-CoV-2 viral load, replication, and lung pathology in Syrian hamsters when administered orally.